...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: The crick didn’t rise, here’s the presentation, finally!

Have to be honest - I'm a little excited again!! Got a feeling this could move quickly - nice to hear they've been working together for several months now. Bring it home!!!

Share
New Message
Please login to post a reply